Drugs.com New Drug ApplicationsOriginal article
Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa
NDA FilingNCX 470Positive
AI Analysis
Summary
Nicox SA announced the submission of an NDA to the FDA for NCX 470 (K-911) in the United States by exclusive partner Kowa. This represents a regulatory milestone for the ophthalmology company's drug candidate.
Importance:7/10
Sentiment:
0.60
FDANDAophthalmologyregulatory
Related Companies
Read the original article
Published by Drugs.com New Drug Applications on July 1, 2026 9:07 PM